All these findings support the assumption that DICER1 syndrome-related TC may develop in a background of MNG, via a stepwise process, involving DICER1 somatic mutations and additional molecular events, distinct from the classic pathways of TC [9, 117]. The gene discussed is DICER1; the disease is DICER1-related tumor predisposition.